NET COMMERCIAL LEASENet Commercial Lease • November 7th, 2018 • Audentes Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
Pursuant to Section 4.B of the lease (the “Lease”) for the premises (the “Premises”) at the Property, between JCN Partners (“Lessor”) and Audentes Therapeutics (“Audentes”), as tenant, dated August _, 2018, Audentes must request a written determination by the City of South San Francisco Planning Division regarding the zoning of the Property (a “Zoning Verification Letter”) not more than twelve (12) months or less than nine (9) months prior to the expiration of the term of the Lease. As such, Audentes hereby requests that a Zoning Verification Letter (or its equivalent) be issued that confirms that the Premises can be reconverted to its originally designated use of Industrial Use (as defined below), including, wholesale, warehouse and distribution under the City’s current zoning ordinance following the termination of the Lease. Below is a background summary that should assist you in issuing the Zoning Verification Letter:
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 7th, 2018 • Audentes Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This Executive Employment Agreement (the “Agreement”) is entered into between Audentes Therapeutics, Inc. (the “Company”) and Natalie Holles (the “Executive”). This Agreement is effective as of September ___, 2018 (the “Effective Date”). This Agreement supersedes and replaces in its entirety the Executive Employment Agreements dated February 14, 2018 and July 21, 2015 between Executive and the Company.
FIRST AMENDMENT TO NET COMMERCIAL LEASECommercial Lease • November 7th, 2018 • Audentes Therapeutics, Inc. • Biological products, (no disgnostic substances)
This First Amendment to Net Commercial Lease (this “Amendment”) dated September 30, 2018, for reference purposes only, is by and between JCN PARTNERS, a California limited partnership (“Lessor”), and AUDENTES THERAPEUTICS, INC., a Delaware corporation (“Lessee”), with reference to the following facts:
